Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
about
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.Influenza vaccines based on virus-like particlesImmune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice.Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particlesAntibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic piSubunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responsesRotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio choleraeRectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesImmune mediators of rotavirus antigenemia clearance in mice.Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G.Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protectionImmunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteinsWhy does the world need another rotavirus vaccine?Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.The gastrointestinal frontier: IgA and virusesDifferential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity.
P2860
Q30359424-A12FF95A-B410-4460-9547-BAC0F042CA53Q30376236-1CB2EF48-ABDE-4018-9813-FEF180467594Q30833219-93FF670D-C803-4584-A018-FC988C1507ADQ33604018-BD948465-C11A-44EB-B1EF-F7D5CBE8653DQ33649920-1B10049B-90F6-41E5-AB1C-42B86A03AD49Q33649962-59208CFF-CE7C-4C6E-BC31-46AA85D57B0BQ33725133-6BE6B23A-B470-472F-B378-69B7054F2661Q33785446-C8A1DF90-C6F5-4D80-BA40-0A714199CD1EQ33840918-FA0D11FB-D536-4BBB-998C-2179783D4A1DQ33845547-9E754E03-7B24-49BF-B7CE-642B623EE3DCQ33846577-357ABC36-C85F-41FB-BB7A-9BE173C74E7BQ33849144-473E221C-F957-42CA-B345-6D9C37110A93Q33946563-B62D1DAE-637D-48BD-BC27-795C7B5FEEC3Q34000362-8C37B17C-2EB8-40AB-96D0-1562C052CF49Q34000827-B622D55C-AF4D-413C-91E8-DD236003BEAAQ34353344-02C190B4-0041-4E56-BAE5-A1E2B53540F4Q34545847-F1B82DAB-07FC-41EA-A782-55E710920F54Q34647668-FC6EA5DD-0282-4252-ABFB-BFCCE401C623Q35140279-CD84468C-2467-457F-90C1-557FE108CBCAQ35155937-BDA93D9B-E9BA-4288-98EA-7A51BFFF4A6BQ35542518-D2ABC116-3538-4BAE-B071-1A04EE8E0B60Q35985896-AF10EE68-E85E-4082-A9B2-31702F459F87Q36822928-4CFD7BE3-645A-45DE-B864-6DA58ACAF8D6Q36846046-5EFBFCFA-11DB-4476-B9B0-596A38B932FFQ38172132-9F08FD99-F020-45D5-BF50-C7D49E2A82CBQ42082721-07C32836-5010-4B5E-8A4F-FCCB01CE01E3
P2860
Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Rotavirus 2/6 viruslike partic ...... tion from rotavirus challenge.
@ast
Rotavirus 2/6 viruslike partic ...... tion from rotavirus challenge.
@en
type
label
Rotavirus 2/6 viruslike partic ...... tion from rotavirus challenge.
@ast
Rotavirus 2/6 viruslike partic ...... tion from rotavirus challenge.
@en
prefLabel
Rotavirus 2/6 viruslike partic ...... tion from rotavirus challenge.
@ast
Rotavirus 2/6 viruslike partic ...... tion from rotavirus challenge.
@en
P2093
P2860
P1433
P1476
Rotavirus 2/6 viruslike partic ...... ction from rotavirus challenge
@en
P2093
P2860
P304
P577
1998-04-01T00:00:00Z